-
1
-
-
0035975394
-
Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer
-
Kapiteijn E., Marijnen C.A., Nagtegaal I.D., et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345 (2001) 638
-
(2001)
N Engl J Med
, vol.345
, pp. 638
-
-
Kapiteijn, E.1
Marijnen, C.A.2
Nagtegaal, I.D.3
-
2
-
-
1842377447
-
Improved survival with preoperative radiotherapy in resectable rectal cancer
-
Swedish Rectal Cancer Trial
-
Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 336 (1997) 980
-
(1997)
N Engl J Med
, vol.336
, pp. 980
-
-
-
3
-
-
24944534960
-
Swedish Rectal Cancer Trial: Long lasting benefits from radiotherapy on survival and local recurrence rate
-
Folkesson J., Birgisson H., Pahlman L., et al. Swedish Rectal Cancer Trial: Long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol 23 (2005) 5644
-
(2005)
J Clin Oncol
, vol.23
, pp. 5644
-
-
Folkesson, J.1
Birgisson, H.2
Pahlman, L.3
-
4
-
-
0031978182
-
Preoperative irradiation affects functional results after surgery for rectal cancer: Results from a randomized study
-
discussion 549
-
Dahlberg M., Glimelius B., Graf W., et al. Preoperative irradiation affects functional results after surgery for rectal cancer: Results from a randomized study. Dis Colon Rectum 41 (1998) 543 discussion 549
-
(1998)
Dis Colon Rectum
, vol.41
, pp. 543
-
-
Dahlberg, M.1
Glimelius, B.2
Graf, W.3
-
5
-
-
34248596246
-
Late adverse effects of radiation therapy for rectal cancer - a systematic overview
-
Birgisson H., Pahlman L., Gunnarsson U., et al. Late adverse effects of radiation therapy for rectal cancer - a systematic overview. Acta Oncol 46 (2007) 504
-
(2007)
Acta Oncol
, vol.46
, pp. 504
-
-
Birgisson, H.1
Pahlman, L.2
Gunnarsson, U.3
-
6
-
-
3342929739
-
Effectiveness of preoperative staging in rectal cancer: Digital rectal examination, endoluminal ultrasound or magnetic resonance imaging?
-
Brown G., Davies S., Williams G.T., et al. Effectiveness of preoperative staging in rectal cancer: Digital rectal examination, endoluminal ultrasound or magnetic resonance imaging?. Br J Cancer 91 (2004) 23
-
(2004)
Br J Cancer
, vol.91
, pp. 23
-
-
Brown, G.1
Davies, S.2
Williams, G.T.3
-
7
-
-
34247270703
-
Preoperative computed tomography staging of nonmetastatic colon cancer predicts outcome: Implications for clinical trials
-
Smith N.J., Bees N., Barbachano Y., et al. Preoperative computed tomography staging of nonmetastatic colon cancer predicts outcome: Implications for clinical trials. Br J Cancer 96 (2007) 1030
-
(2007)
Br J Cancer
, vol.96
, pp. 1030
-
-
Smith, N.J.1
Bees, N.2
Barbachano, Y.3
-
8
-
-
33947187210
-
Recommendations for the reporting of surgically resected specimens of colorectal carcinoma
-
Jass J.R., O'Brien M.J., Riddell R.H., et al. Recommendations for the reporting of surgically resected specimens of colorectal carcinoma. Hum Pathol 38 (2007) 537
-
(2007)
Hum Pathol
, vol.38
, pp. 537
-
-
Jass, J.R.1
O'Brien, M.J.2
Riddell, R.H.3
-
9
-
-
33846595479
-
ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer
-
Locker G.Y., Hamilton S., Harris J., et al. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol 24 (2006) 5313
-
(2006)
J Clin Oncol
, vol.24
, pp. 5313
-
-
Locker, G.Y.1
Hamilton, S.2
Harris, J.3
-
10
-
-
34249881055
-
Tumor markers in colorectal cancer: European Group on Tumor Markers (EGTM) guidelines for clinical use
-
Duffy M.J., van Dalen A., Haglund C., et al. Tumor markers in colorectal cancer: European Group on Tumor Markers (EGTM) guidelines for clinical use. Eur J Cancer 43 (2007) 1348
-
(2007)
Eur J Cancer
, vol.43
, pp. 1348
-
-
Duffy, M.J.1
van Dalen, A.2
Haglund, C.3
-
11
-
-
34547102747
-
Matrix metalloproteinases in rectal mucosa, tumor and plasma: Response after preoperative irradiation
-
Angenete E., Langenskiold M., Falk P., et al. Matrix metalloproteinases in rectal mucosa, tumor and plasma: Response after preoperative irradiation. Int J Colorectal Dis 22 (2007) 667
-
(2007)
Int J Colorectal Dis
, vol.22
, pp. 667
-
-
Angenete, E.1
Langenskiold, M.2
Falk, P.3
-
12
-
-
34648829019
-
Transforming growth factor beta-1 in rectal tumor, mucosa and plasma in relation to radiotherapy and clinical outcome in rectal cancer patients
-
Angenete E., Langenskiold M., Palmgren I., et al. Transforming growth factor beta-1 in rectal tumor, mucosa and plasma in relation to radiotherapy and clinical outcome in rectal cancer patients. Int J Colorectal Dis 22 (2007) 1331
-
(2007)
Int J Colorectal Dis
, vol.22
, pp. 1331
-
-
Angenete, E.1
Langenskiold, M.2
Palmgren, I.3
-
13
-
-
0033981473
-
The plasminogen activation system in tumor growth, invasion, and metastasis
-
Andreasen P.A., Egelund R., and Petersen H.H. The plasminogen activation system in tumor growth, invasion, and metastasis. Cell Mol Life Sci 57 (2000) 25
-
(2000)
Cell Mol Life Sci
, vol.57
, pp. 25
-
-
Andreasen, P.A.1
Egelund, R.2
Petersen, H.H.3
-
14
-
-
0036631895
-
Plasmin/plasminogen system in colorectal cancer
-
Berger D.H. Plasmin/plasminogen system in colorectal cancer. World J Surg 26 (2002) 767
-
(2002)
World J Surg
, vol.26
, pp. 767
-
-
Berger, D.H.1
-
15
-
-
0033801887
-
Urokinase-type plasminogen activator and its receptor in colorectal cancer: Independent prognostic factors of metastasis and cancer-specific survival and potential therapeutic targets
-
Yang J.L., Seetoo D., Wang Y., et al. Urokinase-type plasminogen activator and its receptor in colorectal cancer: Independent prognostic factors of metastasis and cancer-specific survival and potential therapeutic targets. Int J Cancer 89 (2000) 431
-
(2000)
Int J Cancer
, vol.89
, pp. 431
-
-
Yang, J.L.1
Seetoo, D.2
Wang, Y.3
-
16
-
-
0027935805
-
Prognostic relevance of plasminogen activators and their inhibitors in colorectal cancer
-
Ganesh S., Sier C.F., Griffioen G., et al. Prognostic relevance of plasminogen activators and their inhibitors in colorectal cancer. Cancer Res 54 (1994) 4065
-
(1994)
Cancer Res
, vol.54
, pp. 4065
-
-
Ganesh, S.1
Sier, C.F.2
Griffioen, G.3
-
17
-
-
0027968819
-
Urokinase-type plasminogen activator and outcome in Dukes' B colorectal cancer
-
Mulcahy H.E., Duffy M.J., Gibbons D., et al. Urokinase-type plasminogen activator and outcome in Dukes' B colorectal cancer. Lancet 344 (1994) 583
-
(1994)
Lancet
, vol.344
, pp. 583
-
-
Mulcahy, H.E.1
Duffy, M.J.2
Gibbons, D.3
-
18
-
-
0035911151
-
The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies
-
Bajou K., Masson V., Gerard R.D., et al. The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies. J Cell Biol 152 (2001) 777
-
(2001)
J Cell Biol
, vol.152
, pp. 777
-
-
Bajou, K.1
Masson, V.2
Gerard, R.D.3
-
19
-
-
16844377832
-
Historical analysis of PAI-1 from its discovery to its potential role in cell motility and disease
-
Dellas C., and Loskutoff D.J. Historical analysis of PAI-1 from its discovery to its potential role in cell motility and disease. Thromb Haemost 93 (2005) 631
-
(2005)
Thromb Haemost
, vol.93
, pp. 631
-
-
Dellas, C.1
Loskutoff, D.J.2
-
20
-
-
0036354852
-
Prediction of distant metastases after curative surgery for rectal cancer
-
Gunther K., Dworak O., Remke S., et al. Prediction of distant metastases after curative surgery for rectal cancer. J Surg Res 103 (2002) 68
-
(2002)
J Surg Res
, vol.103
, pp. 68
-
-
Gunther, K.1
Dworak, O.2
Remke, S.3
-
21
-
-
0033573059
-
Larger and more invasive colorectal carcinoma contains larger amounts of plasminogen activator inhibitor type 1 and its relative ratio over urokinase receptor correlates well with tumor size
-
Abe J., Urano T., Konno H., et al. Larger and more invasive colorectal carcinoma contains larger amounts of plasminogen activator inhibitor type 1 and its relative ratio over urokinase receptor correlates well with tumor size. Cancer 86 (1999) 2602
-
(1999)
Cancer
, vol.86
, pp. 2602
-
-
Abe, J.1
Urano, T.2
Konno, H.3
-
22
-
-
27144449936
-
Plasminogen activator inhibitor-1 as a potential marker for the malignancy of colorectal cancer
-
Sakakibara T., Hibi K., Koike M., et al. Plasminogen activator inhibitor-1 as a potential marker for the malignancy of colorectal cancer. Br J Cancer 93 (2005) 799
-
(2005)
Br J Cancer
, vol.93
, pp. 799
-
-
Sakakibara, T.1
Hibi, K.2
Koike, M.3
-
23
-
-
0033835299
-
Preoperative plasma plasminogen activator inhibitor type-1 and serum C-reactive protein levels in patients with colorectal cancer. The RANX05 Colorectal Cancer Study Group
-
Nielsen H.J., Christensen I.J., Sorensen S., et al. Preoperative plasma plasminogen activator inhibitor type-1 and serum C-reactive protein levels in patients with colorectal cancer. The RANX05 Colorectal Cancer Study Group. Ann Surg Oncol 7 (2000) 617
-
(2000)
Ann Surg Oncol
, vol.7
, pp. 617
-
-
Nielsen, H.J.1
Christensen, I.J.2
Sorensen, S.3
-
24
-
-
0032515761
-
Association between plasma concentrations of plasminogen activator inhibitor-1 and survival in patients with colorectal cancer
-
Nielsen H.J., Pappot H., Christensen I.J., et al. Association between plasma concentrations of plasminogen activator inhibitor-1 and survival in patients with colorectal cancer. BMJ 316 (1998) 829
-
(1998)
BMJ
, vol.316
, pp. 829
-
-
Nielsen, H.J.1
Pappot, H.2
Christensen, I.J.3
-
25
-
-
0037102368
-
Enhanced benefit from adjuvant chemotherapy in breast cancer patients classified high-risk according to urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (n = 3424)
-
Harbeck N., Kates R.E., Look M.P., et al. Enhanced benefit from adjuvant chemotherapy in breast cancer patients classified high-risk according to urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (n = 3424). Cancer Res 62 (2002) 4617
-
(2002)
Cancer Res
, vol.62
, pp. 4617
-
-
Harbeck, N.1
Kates, R.E.2
Look, M.P.3
-
26
-
-
0033014499
-
Invasion marker PAI-1 remains a strong prognostic factor after long-term follow-up both for primary breast cancer and following first relapse
-
Harbeck N., Thomssen C., Berger U., et al. Invasion marker PAI-1 remains a strong prognostic factor after long-term follow-up both for primary breast cancer and following first relapse. Breast Cancer Res Treat 54 (1999) 147
-
(1999)
Breast Cancer Res Treat
, vol.54
, pp. 147
-
-
Harbeck, N.1
Thomssen, C.2
Berger, U.3
-
27
-
-
71849104860
-
Protein measurement with the folin phenol reagent
-
Lowry O., Rosebrough N.J., Farr A.L., et al. Protein measurement with the folin phenol reagent. J Biol Chem 193 (1951) 265
-
(1951)
J Biol Chem
, vol.193
, pp. 265
-
-
Lowry, O.1
Rosebrough, N.J.2
Farr, A.L.3
-
28
-
-
0032414396
-
Differential effect of radiation on endothelial cell function in rectal cancer and normal rectum
-
Richter K.K., Fink L.M., Hughes B.M., et al. Differential effect of radiation on endothelial cell function in rectal cancer and normal rectum. Am J Surg 176 (1998) 642
-
(1998)
Am J Surg
, vol.176
, pp. 642
-
-
Richter, K.K.1
Fink, L.M.2
Hughes, B.M.3
-
29
-
-
0037403588
-
The plasminogen activator and matrix metalloproteinase systems in colorectal cancer: Relationship to tumor pathology
-
Baker E.A., and Leaper D.J. The plasminogen activator and matrix metalloproteinase systems in colorectal cancer: Relationship to tumor pathology. Eur J Cancer 39 (2003) 981
-
(2003)
Eur J Cancer
, vol.39
, pp. 981
-
-
Baker, E.A.1
Leaper, D.J.2
-
30
-
-
0033668753
-
Plasminogen activator system, vascular endothelial growth factor, and colorectal cancer progression
-
Baker E.A., Bergin F.G., and Leaper D.J. Plasminogen activator system, vascular endothelial growth factor, and colorectal cancer progression. Mol Pathol 53 (2000) 307
-
(2000)
Mol Pathol
, vol.53
, pp. 307
-
-
Baker, E.A.1
Bergin, F.G.2
Leaper, D.J.3
-
31
-
-
29744447032
-
Expression and activation of MMP -2, -3, -9, -14 are induced in rat colon after abdominal X-irradiation
-
Strup-Perrot C., Vozenin-Brotons M.C., Vandamme M., et al. Expression and activation of MMP -2, -3, -9, -14 are induced in rat colon after abdominal X-irradiation. Scand J Gastroenterol 41 (2006) 60
-
(2006)
Scand J Gastroenterol
, vol.41
, pp. 60
-
-
Strup-Perrot, C.1
Vozenin-Brotons, M.C.2
Vandamme, M.3
-
32
-
-
0035878875
-
Redox modulation of the pro-fibrogenic mediator plasminogen activator inhibitor-1 following ionizing radiation
-
Zhao W., Spitz D.R., Oberley L.W., et al. Redox modulation of the pro-fibrogenic mediator plasminogen activator inhibitor-1 following ionizing radiation. Cancer Res 61 (2001) 5537
-
(2001)
Cancer Res
, vol.61
, pp. 5537
-
-
Zhao, W.1
Spitz, D.R.2
Oberley, L.W.3
-
33
-
-
23844458933
-
Radiation and transforming growth factor-beta cooperate in transcriptional activation of the profibrotic plasminogen activator inhibitor-1 gene
-
Hageman J., Eggen B.J., Rozema T., et al. Radiation and transforming growth factor-beta cooperate in transcriptional activation of the profibrotic plasminogen activator inhibitor-1 gene. Clin Cancer Res 11 (2005) 5956
-
(2005)
Clin Cancer Res
, vol.11
, pp. 5956
-
-
Hageman, J.1
Eggen, B.J.2
Rozema, T.3
-
34
-
-
0345269072
-
Radiotherapy does not compensate for positive resection margins in rectal cancer patients: Report of a multicenter randomized trial
-
Marijnen C.A., Nagtegaal I.D., Kapiteijn E., et al. Radiotherapy does not compensate for positive resection margins in rectal cancer patients: Report of a multicenter randomized trial. Int J Radiat Oncol Biol Phys 55 (2003) 1311
-
(2003)
Int J Radiat Oncol Biol Phys
, vol.55
, pp. 1311
-
-
Marijnen, C.A.1
Nagtegaal, I.D.2
Kapiteijn, E.3
-
35
-
-
0031902286
-
Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization
-
Bajou K., Noel A., Gerard R.D., et al. Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization. Nat Med 4 (1998) 923
-
(1998)
Nat Med
, vol.4
, pp. 923
-
-
Bajou, K.1
Noel, A.2
Gerard, R.D.3
|